Sustained perfusion of revascularized bioengineered livers heterotopically transplanted into immunosuppressed pigs
- 14 October 2019
- journal article
- research article
- Published by Springer Nature in Nature Biomedical Engineering
- Vol. 4 (4) , 437-445
Abstract
Implanted bioengineered livers have not exceeded three days of continuous perfusion. Here we show that decellularized whole porcine livers revascularized with human umbilical vein endothelial cells and implanted heterotopically into immunosuppressed pigs whose spleens had been removed can sustain perfusion for up to 15 days. We identified peak glucose consumption rate as a main predictor of the patency of the revascularized bioengineered livers (rBELs). Heterotopic implantation of rBELs into pigs in the absence of anticoagulation therapy led to sustained perfusion for three days, followed by a pronounced immune responses directed against the human endothelial cells. A 10 day steroid-based immunosuppression protocol and a splenectomy at the time of rBEL implantation reduced the immune responses and resulted in continuous perfusion of the rBELs for over two weeks. We also show that the human endothelial cells in the perfused rBELs colonize the liver sinusoids and express sinusoidal endothelial markers similar to those in normal liver tissue. Revascularized liver scaffolds that can maintain blood perfusion at physiological pressures might eventually help to overcome the chronic shortage of transplantable human livers.Keywords
Funding Information
- U.S. Department of Health & Human Services | NIH | Center for Information Technology (R01DK117861, R03DK113339, R01DK106667)
This publication has 41 references indexed in Scilit:
- Hemocompatibility improvement of perfusion-decellularized clinical-scale liver scaffold through heparin immobilizationScientific Reports, 2015
- Base structure consisting of an endothelialized vascular-tree network and hepatocytes for whole liver engineeringJournal of Bioscience and Bioengineering, 2013
- Human-Scale Whole-Organ Bioengineering for Liver Transplantation: A Regenerative Medicine ApproachCell Transplantation, 2013
- Use of Decellularized Porcine Liver for Engineering Humanized Liver OrganJournal of Surgical Research, 2012
- Whole-Organ Tissue Engineering: Decellularization and Recellularization of Three-Dimensional Matrix ScaffoldsAnnual Review of Biomedical Engineering, 2011
- A Whole-Organ Regenerative Medicine Approach for Liver ReplacementTissue Engineering Part C: Methods, 2011
- Construction of a Portal Implantable Functional Tissue-Engineered Liver Using Perfusion-Decellularized Matrix and Hepatocytes in RatsCell Transplantation, 2011
- Decellularized liver matrix as a carrier for the transplantation of human fetal and primary hepatocytes in mice aLiver Transplantation, 2011
- The use of whole organ decellularization for the generation of a vascularized liver organoidHepatology, 2010
- Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrixNature Medicine, 2010